Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium

被引：0
|
作者：
AI Catrina
S Ernestam
E af Klint
L Klareskog
AK Ulfgren
机构：
[1] Karolinska Institutet/Hospital,Rheumatology Department
[2] Huddinge Hospital,Rheumatology Department
来源：
Arthritis Res Ther | / 6卷
关键词：
Rheumatoid Arthritis; Tumour Necrosis Factor; Infliximab; Etanercept; Active Rheumatoid Arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Anti-tumour necrosis factor (TNF)-α therapy (etanercept)
    Maya Buch
    Arthritis Research & Therapy, 4 (1)
  • [42] Anti-tumour necrosis factor therapy in the West Midlands
    Bartram, D
    Sheeran, T
    Price, T
    Mulherin, D
    RHEUMATOLOGY, 2004, 43 (03) : 400 - 400
  • [43] Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis
    Bilsborough, William
    Keen, Helen
    Taylor, Andrew
    O'Driscoll, Gerard J.
    Arnolda, Leonard
    Green, Daniel J.
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1125 - 1131
  • [44] Anti-tumour necrosis factor therapy in seronegative spondyloarthritis
    Swales, C
    Bowness, P
    CLINICAL MEDICINE, 2005, 5 (03) : 219 - 222
  • [45] Efficacy and Safety of Anti-Tumour Necrosis Factor in Elderly Patients with Rheumatoid Arthritis: An Observational Study
    Matteo Filippini
    Chiara Bazzani
    Ennio Giulio Favalli
    Antonio Marchesoni
    Fabiola Atzeni
    Piercarlo Sarzi-Puttini
    Francesca Bobbio Pallavicini
    Roberto Caporali
    Roberto Gorla
    Clinical Reviews in Allergy & Immunology, 2010, 38 : 90 - 96
  • [46] Association of baseline cytokine levels with anti-tumour necrosis factor treatment response in rheumatoid arthritis
    Gibson, David S.
    McGeough, Cathy M.
    Slevin, Mary M.
    Wright, Gary
    Gardiner, Philip
    Murray, Helena A.
    Latten, Mark J.
    Crockard, Martin A.
    Lamont, John V.
    Bjourson, Anthony J.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [47] What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
    Feldmann, M
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 111 (04) : 362 - 365
  • [48] Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis
    Finckh, A.
    Simard, J. F.
    Gabay, C.
    Guerne, P. -A.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (06) : 746 - 752
  • [49] Does sex or ethnicity impact anti-tumour necrosis factor agent use in rheumatoid arthritis?
    Dennison, Elaine M.
    Jameson, Karen A.
    Marks, Jonathan
    Watson, Kath
    Hyrich, Kimme
    Symmons, Deborah
    Cooper, Cyrus
    RHEUMATOLOGY, 2017, 56 (04) : 663 - 665
  • [50] Efficacy and Safety of Anti-Tumour Necrosis Factor in Elderly Patients with Rheumatoid Arthritis: An Observational Study
    Filippini, Matteo
    Bazzani, Chiara
    Favalli, Ennio Giulio
    Marchesoni, Antonio
    Atzeni, Fabiola
    Sarzi-Puttini, Piercarlo
    Pallavicini, Francesca Bobbio
    Caporali, Roberto
    Gorla, Roberto
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2010, 38 (2-3) : 90 - 96
12345